High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs.
Emi SometaniHayato HikitaKazuhiro MuraiHidenori ToyodaSatoshi TanakaTsugiko OzeJihyun SungAkiyoshi ShimodaMakoto FukuokaSatoshi ShigenoKeisuke FukutomiKumiko ShiraiYuki TahataYoshinobu SaitoAkira NishioKunimaro FurutaTakahiro KodamaRyotaro SakamoriTomohide TatsumiEiji MitaAkihiro UmezawaYasuhito TanakaTetsuo TakeharaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2024)
High serum GDF15 is an independent risk factor for the occurrence of HCC in CHB patients treated with nucleos(t)ide analogs.